DaVita, Inc. provides dialysis services in the United States for patients suffering from chronic kidney failure, which is also known as end stage renal disease (ESRD). The company operates kidney dialysis centers, and provides related medical services primarily in dialysis centers and in contracted hospitals. Its services include outpatient dialysis services; hospital inpatient dialysis services; and ancillary services, such as ESRD laboratory services, vascular access services, and disease management services. In addition, the company conducts research trials of new pharmaceuticals and medical devices with dialysis patients, and provides administrative support for research conducted by its affiliated nephrology practices. As of December 31, 2005, DaVita operated or provided administrative services to 1,233 outpatient dialysis centers, serving approximately 96,000 patients in 41 states, and the District of Columbia; and offered acute inpatient dialysis services in approximately 795 hospitals. The company was incorporated in 1994 and is headquartered in El Segundo, California.
Earning speculation.